These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 23813948
1. Effects of low-dose mirtazapine on driving performance in healthy volunteers. Iwamoto K, Kawano N, Sasada K, Kohmura K, Yamamoto M, Ebe K, Noda Y, Ozaki N. Hum Psychopharmacol; 2013 Sep; 28(5):523-8. PubMed ID: 23813948 [Abstract] [Full Text] [Related]
2. Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers. Sasada K, Iwamoto K, Kawano N, Kohmura K, Yamamoto M, Aleksic B, Ebe K, Noda Y, Ozaki N. Hum Psychopharmacol; 2013 May; 28(3):281-6. PubMed ID: 23661283 [Abstract] [Full Text] [Related]
7. A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition. Theunissen EL, Street D, Højer AM, Vermeeren A, van Oers A, Ramaekers JG. Clin Pharmacol Ther; 2013 Jun; 93(6):493-501. PubMed ID: 23588319 [Abstract] [Full Text] [Related]
8. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers. Miyata A, Iwamoto K, Kawano N, Kohmura K, Yamamoto M, Aleksic B, Ebe K, Noda A, Noda Y, Iritani S, Ozaki N. Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998 [Abstract] [Full Text] [Related]
10. A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance. Ridout F, Meadows R, Johnsen S, Hindmarch I. Hum Psychopharmacol; 2003 Jun; 18(4):261-9. PubMed ID: 12766930 [Abstract] [Full Text] [Related]
13. The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients. Brunnauer A, Laux G, David I, Fric M, Hermisson I, Möller HJ. J Clin Psychiatry; 2008 Dec; 69(12):1880-6. PubMed ID: 19203476 [Abstract] [Full Text] [Related]
14. A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic. Ramaekers G, Lamers J, Verhey F, Muntjewerff D, Mobbs E, Sanders N, Lewis M, Lockton A. Psychopharmacology (Berl); 2002 Jan; 159(2):203-10. PubMed ID: 11862350 [Abstract] [Full Text] [Related]
15. The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial. Iwamoto K, Takahashi M, Nakamura Y, Kawamura Y, Ishihara R, Uchiyama Y, Ebe K, Noda A, Noda Y, Yoshida K, Iidaka T, Ozaki N. Hum Psychopharmacol; 2008 Jul; 23(5):399-407. PubMed ID: 18383000 [Abstract] [Full Text] [Related]
17. Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study. Sarris J, Laporte E, Scholey A, King R, Pipingas A, Schweitzer I, Stough C. Traffic Inj Prev; 2013 Jul; 14(1):13-7. PubMed ID: 23259514 [Abstract] [Full Text] [Related]
18. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. Pahwa R, Lyons KE. Mov Disord; 2003 May; 18(5):584-7. PubMed ID: 12722174 [Abstract] [Full Text] [Related]
19. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. Leufkens TR, Lund JS, Vermeeren A. J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733 [Abstract] [Full Text] [Related]